Inactive Instrument
Irwin Naturals Inc. Stock Canadian Securities Exchange
Stocks
IWIN
CA46414Q1054
Pharmaceuticals
OTC Markets Traded| Market Cap | 483K 418K 391K 357K 673K 46.07M 684K 4.58M 1.8M 23.05M 1.81M 1.77M 76.75M | P/E 2021 |
105x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.19M 17M 15.54M 29.28M 2B 29.74M 199M 78.23M 1B 78.89M 77.17M 3.34B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.31x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 01/01/1994 |
Mark Green
DFI | Director of Finance/CFO | - | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 18,240 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 708K | |
| +2.58% | +8.11% | +90.85% | +132.54% | 1,057B | |
| +0.82% | +2.04% | +49.36% | +50.79% | 625B | |
| +0.07% | -0.31% | +23.01% | +61.35% | 435B | |
| +1.58% | +4.80% | +51.48% | +39.79% | 363B | |
| +0.65% | +1.85% | +32.06% | +39.99% | 296B | |
| +0.79% | +4.26% | +8.64% | +7.42% | 249B | |
| +0.84% | +8.73% | +44.49% | +57.19% | 222B | |
| +0.34% | +1.27% | -5.10% | -50.94% | 209B | |
| +0.35% | +1.55% | +10.55% | +66.48% | 165B | |
| Average | +0.66% | +0.94% | +33.93% | +44.96% | 402.31B | |
| Weighted average by Cap. | +1.04% | +1.33% | +49.10% | +66.20% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 86.87M 81.19M 74.21M 140M 9.57B 142M 952M 374M 4.79B 377M 369M 15.95B | 89.47M 77.45M 72.4M 66.17M 125M 8.53B 127M 849M 333M 4.27B 336M 329M 14.22B |
| Net income | 8.62M 7.46M 6.97M 6.37M 12.01M 822M 12.19M 81.75M 32.08M 411M 32.35M 31.64M 1.37B | -3.99M -3.46M -3.23M -2.95M -5.56M -381M -5.65M -37.88M -14.86M -190M -14.99M -14.66M -634M |
| Net Debt | 9.35M 8.1M 7.57M 6.92M 13.03M 892M 13.24M 88.75M 34.82M 446M 35.12M 34.35M 1.49B | 20.53M 17.77M 16.61M 15.18M 28.61M 1.96B 29.06M 195M 76.43M 979M 77.08M 75.4M 3.26B |
Employees
-
Sector
Pharmaceuticals
